Unlike acute cases of hives, physical urticaria is not caused by allergies, viral infections, or any internal causes. Instead, it’s caused by exposure to various forms of physical stimuli.

Urticaria may be acute or chronic. As opposed to acute urticaria, chronic urticaria is defined by recurrent episodes occurring at least twice a week for 6 weeks (Grattan, Sabroe, & Greaves, 2002).

Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as ...

Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease ...

Abella B, et al. (2020). Intravenous cetirizine versus intravenous diphenhydramine for the treatment of acute urticaria: A phase III randomized controlled noninferiority trial. https://pubmed.ncbi ...

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated statistically significant ...

Cite this: Classification and Treatment of Urticaria: A Brief Review - Medscape - Oct 01, 2005. ... (papular urticaria) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid  Approval based on pivotal results showing improvements in sustained disease remission and ...

Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use co ...